PDF
ePub
Citation
Print
Abstract
Immature ganglion cell (IGC) is known for its relationship with intestinal motility and its impact on postoperative functional outcomes of Hirschsprung's disease (HD). There are few studies on the relationship between intestinal dysmotility and IGC in HD patients. 67 patients pathologically diagnosed with HD and who received definitive operation in Seoul National University Children's Hospital from 2010 to 2011 were included. 10 patients were excluded due to inadequate immunohistochemical staining results. The proximal end of resected ganglionic segment was evaluated with immunohistochemistry examination with MAP-2, a marker of ganglionic cells and bcl-2, a marker of IGCs The median age at operation was 155 (15-4678) day-old. 55 (96.5%) patients positive for bcl-2, were regarded as having IGC, and 2 (3.5%) patients positive for MAP-2 but negative for bcl-2, were regarded as having only mature ganglion cells. In the bcl-2 positive group, there were 7 patients (12.7%) with constipation, 15 patients (27.3%) with soiling, 3 patients (5.5%) with perianal excoriation and 6 patients (10.9%) with medication use. In bcl-2 negative group, intestinal dysmotility was not seen. There was no statistical significance in the two groups. Considering that HD is diagnosed at a young age, the rate of IGC present is very high and it might be inappropriate to relate IGC to functional outcome at young ages.
Figures and Tables
References
1. Lyford G, Foxx-Orenstein A. Chronic intestinal pseudoobstruction. Curr Treat Options Gastroenterol. 2004; 7:317–325.
2. Toyosaka A, Okamoto E, Okasora T, Nose K, Tomimoto Y. Clinical, laboratory and prognostic features of congenital large intestinal motor dysfunction (pseudo-Hirschsprung's disease). Clin Auton Res. 1993; 3:243–248.
3. Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013; 25:368–374.
4. Miyahara K, Kato Y, Seki T, Arakawa A, Lane GJ, Yamataka A. Neuronal immaturity in normoganglionic colon from cases of Hirschsprung disease, anorectal malformation, and idiopathic constipation. J Pediatr Surg. 2009; 44:2364–2368.
5. Burtelow MA, Longacre TA. Utility of microtubule associated protein-2 (MAP-2) immunohistochemistry for identification of ganglion cells in paraffin-embedded rectal suction biopsies. Am J Surg Pathol. 2009; 33:1025–1030.
6. Park SH, Min H, Chi JG, Park KW, Yang HR, Seo JK. Immunohistochemical studies of pediatric intestinal pseudo-obstruction: bcl2, a valuable biomarker to detect immature enteric ganglion cells. Am J Surg Pathol. 2005; 29:1017–1024.
7. Kim DY, Lee SC, Park KW, Kim WK. Cathepsin D Expression in Intestinal Ganglion Cells of Neonate. J Korean Assoc Pediatr Surg. 1999; 5:39–44.
8. Feichter S, Meier-Ruge WA, Bruder E. The histopathology of gastrointestinal motility disorders in children. Semin Pediatr Surg. 2009; 18:206–211.
9. Ieiri S, Nakatsuji T, Akiyoshi J, Higashi M, Hashizume M, Suita S, Taguchi T. Long-term outcomes and the quality of life of Hirschsprung disease in adolescents who have reached 18 years or older--a 47-year single-institute experience. J Pediatr Surg. 2010; 45:2398–2402.
10. Menezes M, Pini Prato A, Jasonni V, Puri P. Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg. 2008; 43:1696–1699.
11. Park K, Choe YM, Kim JY, Choi SK, Heo YS, Lee KY, Kim SJ, Cho YU, Ahn SI, Hong KC, Shin SH, Kim KR, Seo JM. Clinical experience with Hirschsprung's disease. J Korean Assoc Pediatr Surg. 2010; 16:162–169.
12. Stensrud KJ, Emblem R, Bjørnland K. Functional outcome after operation for Hirschsprung disease--transanal vs transabdominal approach. J Pediatr Surg. 2010; 45:1640–1644.
13. Sun X, Wang R, Zhang L, Li D, Li Y. Efficacy of pelvic floor muscle training for the treatment of fecal incontinence after Soave procedure for Hirschsprung disease. Eur J Pediatr Surg. 2012; 22:300–304.
14. Levitt MA, Dickie B, Pena A. The Hirschsprungs patient who is soiling after what was considered a 'successful' pull-through. Semin Pediatr Surg. 2012; 21:344–353.
15. Friedmacher F, Puri P. Residual aganglionosis after pull-through operation for Hirschsprung's disease: a systematic review and meta-analysis. Pediatr Surg Int. 2011; 27:1053–1057.
16. Bettolli M, De Carli C, Jolin-Dahel K, Bailey K, Khan HF, Sweeney B, Krantis A, Staines WA, Rubin S. Colonic dysmotility in postsurgical patients with Hirschsprung's disease. Potential significance of abnormalities in the interstitial cells of Cajal and the enteric nervous system. J Pediatr Surg. 2008; 43:1433–1438.
17. Kapur RP. Practical pathology and genetics of Hirschsprung's disease. Semin Pediatr Surg. 2009; 18:212–223.
18. Lawal TA, Chatoorgoon K, Collins MH, Coe A, Peña A, Levitt MA. Redo pull-through in Hirschsprung's [corrected] disease for obstructive symptoms due to residual aganglionosis and transition zone bowel. J Pediatr Surg. 2011; 46:342–347.
19. Venugopal S, Mancer K, Shandling B. The validity of rectal biopsy in relation to morphology and distribution of ganglion cells. J Pediatr Surg. 1981; 16:433–437.
20. Smith B. Pre- and postnatal development of the ganglion cells of the rectum and its surgical implications. J Pediatr Surg. 1968; 3:386–391.
21. Song Y, Li JC, Li MJ. Bcl-2 expression in enteric neurons of Hirschsprungs disease and its significance. Shi Yan Sheng Wu Xue Bao. 2002; 35:155–158.
22. Wester T, Olsson Y, Olsen L. Expression of bcl-2 in enteric neurons in normal human bowel and Hirschsprung's disease. Arch Pathol Lab Med. 1999; 123:1264–1268.
23. Puri P. Variant Hirschsprung's disease. J Pediatr Surg. 1997; 32:149–157.
24. Ure BM, Holschneider AM, Schulten D, Meier-Ruge W. Clinical impact of intestinal neuronal malformations: a prospective study in 141 patients. Pediatr Surg Int. 1997; 12:377–382.
XML Download